JAZZ FY 2014 Earnings — Jazz Pharmaceuticals plc Revenue & Financial Results | Market Cap Arena

JAZZJazz Pharmaceuticals plc

$11B

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1.2B+34.4% YoY

Gross Profit

$1.1B90.0% margin

Operating Income

$196M16.7% margin

Net Income

$58M5.0% margin

EPS (Diluted)

$0.93

Cash Flow

Operating Cash Flow

$406M

Free Cash Flow

$167M

Stock-Based Comp.

$70M

Balance Sheet

Total Assets

$3.3B

Total Liabilities

$2.0B

Stockholders' Equity

$1.4B

Cash & Equivalents

$684M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.2B	$872M	+34.4%
Gross Profit	$1.1B	$770M	+37.0%
Operating Income	$196M	$340M	-42.5%
Net Income	$58M	$216M	-73.0%